These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9093669

  • 1. DNA analysis of human cholesteatomas.
    Desloge RB, Carew JF, Finstad CL, Steiner MG, Sassoon J, Levenson MJ, Staiano-Coico L, Parisier SC, Albino AP.
    Am J Otol; 1997 Mar; 18(2):155-9. PubMed ID: 9093669
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cholesteatoma: a molecular and cellular puzzle.
    Albino AP, Kimmelman CP, Parisier SC.
    Am J Otol; 1998 Jan; 19(1):7-19. PubMed ID: 9455941
    [Abstract] [Full Text] [Related]

  • 4. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R, Welkoborsky HJ, Mann W.
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [Abstract] [Full Text] [Related]

  • 5. [DNA cytometric studies of cholesteatoma of the middle ear].
    Bollmann R, Knopp U, Tolsdorff P.
    HNO; 1991 Aug; 39(8):313-4. PubMed ID: 1938497
    [Abstract] [Full Text] [Related]

  • 6. Alteration in cholesteatoma fibroblasts: induction of neoplastic-like phenotype.
    Parisier SC, Agresti CJ, Schwartz GK, Han JC, Albino AP.
    Am J Otol; 1993 Mar; 14(2):126-30. PubMed ID: 8503484
    [Abstract] [Full Text] [Related]

  • 7. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.
    Albino AP, Reed JA, Bogdany JK, Sassoon J, Parisier SC.
    Am J Otol; 1998 May; 19(3):266-72. PubMed ID: 9596172
    [Abstract] [Full Text] [Related]

  • 8. Immune cell profile in invasive cholesteatomas: preliminary findings.
    Hussein MR, Sayed RH, Abu-Dief EE.
    Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
    [Abstract] [Full Text] [Related]

  • 9. Variations in DNA aneuploid cell content during tumor dissociation in human colon and head and neck cancers analyzed by flow cytometry.
    Ensley JF, Maciorowski Z, Hassan M, Pietraszkiewicz H, Sakr W, Heilbrun LK.
    Cytometry; 1993 Apr; 14(5):550-8. PubMed ID: 8354128
    [Abstract] [Full Text] [Related]

  • 10. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M, Ebmeyer J, Buchbinder A, Sudhoff H.
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [Abstract] [Full Text] [Related]

  • 11. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
    Ayache S, Tramier B, Strunski V.
    Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
    [Abstract] [Full Text] [Related]

  • 12. Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
    Ecsedi S, Rákosy Z, Vízkeleti L, Juhász A, Sziklai I, Adány R, Balázs M.
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):635-40. PubMed ID: 18984256
    [Abstract] [Full Text] [Related]

  • 13. Telomerase activity and cell proliferation index in cholesteatoma.
    Lee SH, Jang YH, Tae K, Park YW, Kang MJ, Kim KR, Park CW.
    Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
    [Abstract] [Full Text] [Related]

  • 14. Cholesteatoma in children.
    Sadé J, Shatz A.
    J Laryngol Otol; 1988 Nov; 102(11):1003-6. PubMed ID: 3209933
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T, Kondo K, Yamasoba T, Suzuki M, Sugasawa M, Kaga K.
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [Abstract] [Full Text] [Related]

  • 16. [DNA character of the cholesteatoma].
    Cui Y, Pan H, Gao Q.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):62-3. PubMed ID: 12541864
    [Abstract] [Full Text] [Related]

  • 17. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J, Pawelczyk T, Bakowska A, Narozny W, Mikaszewski B.
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of p63 and survivin in cholesteatomas.
    Park HR, Min SK, Min K, Jun SY, Seo J, Kim HJ.
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [Abstract] [Full Text] [Related]

  • 19. [Cholesteatomas in the tympanic membrane separated from the middle ear and the mastoid].
    Charachon R, Roux O, Dumas G.
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Mar; 30(3):157-67. PubMed ID: 6453941
    [No Abstract] [Full Text] [Related]

  • 20. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD, Gerkin RD, Locke D, Macias MP.
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.